Literature DB >> 20113838

Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25).

Joana Santos1, Nuno Cerveira, Cecília Correia, Susana Lisboa, Manuela Pinheiro, Lurdes Torres, Susana Bizarro, Joana Vieira, Luisa Viterbo, José M Mariz, Manuel R Teixeira.   

Abstract

We present the characterization at the RNA level of an acute myeloid leukemia with a t(11;17)(q23;q25) and a MLL rearrangement demonstrated by FISH. Molecular analysis led to the identification of two coexistent in-frame MLL-SEPT9 fusion transcripts (variants 1 and 2), presumably resulting from alternative splicing. Real-time quantitative RT-PCR analysis showed that the relative expression of the MLL-SEPT9 fusion variant 2 was 1.88 fold higher than the relative expression of MLL-SEPT9 fusion variant 1. This is the first description of a MLL-SEPT9 fusion resulting in coexistence of two alternative splicing variants, each of which previously found isolated in myeloid leukemias. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113838     DOI: 10.1016/j.cancergencyto.2009.10.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.

Authors:  Nuno Cerveira; Susana Lisboa; Cecília Correia; Susana Bizarro; Joana Santos; Lurdes Torres; Joana Vieira; João D Barros-Silva; Dulcineia Pereira; Cláudia Moreira; Claus Meyer; Tereza Oliva; Ilídia Moreira; Ângelo Martins; Luísa Viterbo; Vítor Costa; Rolf Marschalek; Armando Pinto; José M Mariz; Manuel R Teixeira
Journal:  Mol Oncol       Date:  2012-07-14       Impact factor: 6.603

2.  Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma.

Authors:  M E Rusiniak; D Kunnev; A Freeland; G K Cady; S C Pruitt
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

3.  A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia.

Authors:  Christopher J Forlenza; Yanming Zhang; JinJuan Yao; Ryma Benayed; Peter Steinherz; Kavitha Ramaswamy; Rachel Kessel; Mikhail Roshal; Neerav Shukla
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.